Cargando…
Non-lytic antibiotic treatment in community-acquired pneumococcal pneumonia does not attenuate inflammation: the PRISTINE trial
BACKGROUND: The inflammatory response in pneumococcal infection is primarily driven by immunoreactive bacterial cell wall components [lipoteichoic acid (LTA)]. An acute release of these components occurs when pneumococcal infection is treated with β-lactam antibiotics. OBJECTIVES: We hypothesized th...
Autores principales: | Groeneveld, Geert H, van der Reyden, Tanny J, Joosten, Simone A, Bootsma, Hester J, Cobbaert, Christa M, de Vries, Jutte J C, Kuijper, Ed J, van Dissel, Jaap T |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6640306/ https://www.ncbi.nlm.nih.gov/pubmed/31106377 http://dx.doi.org/10.1093/jac/dkz207 |
Ejemplares similares
-
Prediction model for pneumonia in primary care patients with an acute respiratory tract infection: role of symptoms, signs, and biomarkers
por: Groeneveld, G. H., et al.
Publicado: (2019) -
Procalcitonin reflects bacteremia and bacterial load in urosepsis syndrome: a prospective observational study
por: van Nieuwkoop, Cees, et al.
Publicado: (2010) -
Clinical factors, C-reactive protein point of care test and chest X-ray in patients with pneumonia: A survey in primary care
por: Groeneveld, Geert H., et al.
Publicado: (2019) -
Role of Nucleotide-Binding Oligomerization Domain-Containing (NOD) 2 in Host Defense during Pneumococcal Pneumonia
por: Hommes, Tijmen J., et al.
Publicado: (2015) -
Procalcitonin, mid-regional proadrenomedullin and C-reactive protein in predicting treatment outcome in community-acquired febrile urinary tract infection
por: Stalenhoef, Janneke Evelyne, et al.
Publicado: (2019)